EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Potential of Optical Genome Mapping in the Diagnosis and Prognosis of Soft Tissue and Bone Tumors

Alejandro Berenguer-Rubio iD, Esperanza Such iD, Neus Torres Hernández iD, Paula González-Rojo iD, Álvaro Díaz-González, Gayane Avetisyan, Carolina Gil-Aparicio, Judith González-López iD, Nicolay Pantoja-Borja, Luis Alberto Rubio-Martínez, Soraya Hernández-Girón, María Soledad Valera-Cuesta und 9 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26062820 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Alejandro Berenguer-Rubio und 20 weiteren Autor:innen. Beteiligte Einrichtung: Cytogenetic Laboratory, Instituto de Investigación Sanitaria La Fe, 46026 València, Spain. Hauptthemen laut MEDLINE: Bone Neoplasms, Soft Tissue Neoplasms, Sarcoma, Chromosome Mapping. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Investigación Sanitaria La Fe, Ministerio de Ciencia, Innovación y Universidades, Generalitat Valenciana.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcomas are rare malignant tumors of mesenchymal origin with a high misdiagnosis rate due to their heterogeneity and low incidence. Conventional diagnostic techniques, such as Fluorescence In Situ Hybridization (FISH) and Next-Generation Sequencing (NGS), have limitations in detecting structural variations (SVs), copy number variations (CNVs), and predicting clinical behavior. Optical genome mapping (OGM) provides high-resolution genome-wide analysis, improving sarcoma diagnosis and prognosis assessment. This study analyzed 53 sarcoma samples using OGM. Ultra-high molecular weight (UHMW) DNA was extracted from core and resection biopsies, and data acquisition was performed with the Bionano Saphyr platform. Bioinformatic pipelines identified structural variations, comparing them with known alterations for each sarcoma subtype. OGM successfully analyzed 62.3% of samples. Diagnostic-defining alterations were found in 95.2% of cases, refining diagnoses and revealing novel oncogenic and tumor suppressor gene alterations. The challenges included DNA extraction and quality issues from some tissue samples. Despite these limitations, OGM proved to be a powerful diagnostic and predictive tool for bone and soft tissue sarcomas, surpassing conventional methods in resolution and scope, enhancing the understanding of sarcoma genetics, and enabling better patient stratification and personalized therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsSoft Tissue NeoplasmsSarcomaChromosome MappingHumansPrognosisDNA Copy Number VariationsFemaleMaleMiddle AgedAdultHigh-Throughput Nucleotide SequencingAgedAdolescentYoung Adult

Stichwörter der Autor:innen

bone tumorscytogeneticsdiagnosisoptical genome mappingsoft tissue tumors

Autor:innen und Institutionen

  • Cytogenetic Laboratory, Instituto de Investigación Sanitaria La Fe, 46026 València, Spain.
  • Department of Hematology, Hospital Universitari i Politècnic La Fe, 46026 València, Spain.
  • Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
  • Pathology Department, Hospital Universitari i Politècnic La Fe, 46026 València, Spain.
  • Radiology Department, Hospital Universitari i Politècnic La Fe, 46026 València, Spain.
  • Medical Oncology Service, Hospital Universitari i Politècnic La Fe, 46026 València, Spain.

ORCID-Profile: Alejandro Berenguer-Rubio, Esperanza Such, Neus Torres Hernández, Paula González-Rojo, Judith González-López

Förderung

  • Instituto de Investigación Sanitaria La Fe
  • Ministerio de Ciencia, Innovación y Universidades
  • Generalitat Valenciana
  • Spanish Ministry of Science and Innovation
  • European Union
  • Department of Education, Culture, Universities and Employment of the Generalitat Valenciana

Zitieren

APA

Berenguer-Rubio, A., Such, E., Hernández, N. T., González-Rojo, P., Díaz-González, Á., Avetisyan, G., Gil-Aparicio, C., González-López, J., Pantoja-Borja, N., Rubio-Martínez, L. A., Hernández-Girón, S., Valera-Cuesta, M. S., Ramírez-Fuentes, C., Simonet-Redondo, M., Díaz-Beveridge, R., de la Calva, C., Amaya-Valero, J. V., Ballester-Ibáñez, C., Liquori, A., …, & Mayordomo-Aranda, E. (2025). Exploring the Potential of Optical Genome Mapping in the Diagnosis and Prognosis of Soft Tissue and Bone Tumors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26062820

Vancouver

Berenguer-Rubio A, Such E, Hernández NT, González-Rojo P, Díaz-González Á, Avetisyan G, et al. Exploring the Potential of Optical Genome Mapping in the Diagnosis and Prognosis of Soft Tissue and Bone Tumors. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26062820

BibTeX
@article{BerenguerRubio2025,
  author = {Berenguer-Rubio, Alejandro and Such, Esperanza and Hernández, Neus Torres and González-Rojo, Paula and Díaz-González, Álvaro and Avetisyan, Gayane and Gil-Aparicio, Carolina and González-López, Judith and Pantoja-Borja, Nicolay and Rubio-Martínez, Luis Alberto and Hernández-Girón, Soraya and Valera-Cuesta, María Soledad and Ramírez-Fuentes, Cristina and Simonet-Redondo, María and Díaz-Beveridge, Roberto and de la Calva, Carolina and Amaya-Valero, José Vicente and Ballester-Ibáñez, Cristina and Liquori, Alessandro and Giner, Francisco and Mayordomo-Aranda, Empar},
  title = {Exploring the Potential of Optical Genome Mapping in the Diagnosis and Prognosis of Soft Tissue and Bone Tumors},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26062820}
}
Kostenlos starten →